CRC having baseline CEA ng/ml level ≥5 was 2.4 times a higher hazard for death than patients with CEA <5 ng/ml (AHR: 2.6, CI: 1.2–5.8). This evidence concerns the gene CEACAM5 and colorectal carcinoma.